182 related articles for article (PubMed ID: 30928063)
21. Computing intraoperative dosimetry for prostate brachytherapy using TRUS and fluoroscopy.
French D; Morris J; Keyes M; Goksel O; Salcudean S
Acad Radiol; 2005 Oct; 12(10):1262-72. PubMed ID: 16179203
[TBL] [Abstract][Full Text] [Related]
22. Feasibility of 4D HDR brachytherapy source tracking using x-ray tomosynthesis: Monte Carlo investigation.
Vasyltsiv R; Qian X; Xu Z; Ryu S; Zhao W; Howansky A
Med Phys; 2023 Aug; 50(8):4695-4709. PubMed ID: 37402139
[TBL] [Abstract][Full Text] [Related]
23. Calculated organ doses using Monte Carlo simulations in a reference male phantom undergoing HDR brachytherapy applied to localized prostate carcinoma.
Candela-Juan C; Perez-Calatayud J; Ballester F; Rivard MJ
Med Phys; 2013 Mar; 40(3):033901. PubMed ID: 23464344
[TBL] [Abstract][Full Text] [Related]
24. Multi-needle Localization with Attention U-Net in US-guided HDR Prostate Brachytherapy.
Zhang Y; Lei Y; Qiu RLJ; Wang T; Wang H; Jani AB; Curran WJ; Patel P; Liu T; Yang X
Med Phys; 2020 Jul; 47(7):2735-2745. PubMed ID: 32155666
[TBL] [Abstract][Full Text] [Related]
25. A novel method for accurate needle-tip identification in trans-rectal ultrasound-based high-dose-rate prostate brachytherapy.
Zheng D; Todor DA
Brachytherapy; 2011; 10(6):466-73. PubMed ID: 21549646
[TBL] [Abstract][Full Text] [Related]
26. BrachyView: proof-of-principle of a novel in-body gamma camera for low dose-rate prostate brachytherapy.
Petasecca M; Loo KJ; Safavi-Naeini M; Han Z; Metcalfe PE; Meikle S; Pospisil S; Jakubek J; Bucci JA; Zaider M; Lerch ML; Qi Y; Rosenfeld AB
Med Phys; 2013 Apr; 40(4):041709. PubMed ID: 23556879
[TBL] [Abstract][Full Text] [Related]
27. Accuracy and variability of high-dose-rate prostate brachytherapy needle tip localization using live two-dimensional and sagittally reconstructed three-dimensional ultrasound.
Hrinivich WT; Hoover DA; Surry K; Edirisinghe C; Velker V; Bauman G; D'Souza D; Fenster A; Wong E
Brachytherapy; 2017; 16(5):1035-1043. PubMed ID: 28764882
[TBL] [Abstract][Full Text] [Related]
28. Real-time electromagnetic tracking-based treatment platform for high-dose-rate prostate brachytherapy: Clinical workflows and end-to-end validation.
Beaulieu L; Racine E; Han DY; Vigneault E; Hsu IC; Cunha JAM
Brachytherapy; 2018; 17(1):103-110. PubMed ID: 28576644
[TBL] [Abstract][Full Text] [Related]
29. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study.
Martin T; Baltas D; Kurek R; Röddiger S; Kontova M; Anagnostopoulos G; Dannenberg T; Buhleier T; Skazikis G; Tunn U; Zamboglou N
Strahlenther Onkol; 2004 Apr; 180(4):225-32. PubMed ID: 15057433
[TBL] [Abstract][Full Text] [Related]
30. In vivo real-time dosimetric verification in high dose rate prostate brachytherapy.
Seymour EL; Downes SJ; Fogarty GB; Izard MA; Metcalfe P
Med Phys; 2011 Aug; 38(8):4785-94. PubMed ID: 21928651
[TBL] [Abstract][Full Text] [Related]
31. High-dose-rate prostate brachytherapy based on registered transrectal ultrasound and in-room cone-beam CT images.
Even AJ; Nuver TT; Westendorp H; Hoekstra CJ; Slump CH; Minken AW
Brachytherapy; 2014; 13(2):128-36. PubMed ID: 24041955
[TBL] [Abstract][Full Text] [Related]
32. Determination of transit dose profile for a (192)Ir HDR source.
Fonseca GP; Rubo RA; Minamisawa RA; dos Santos GR; Antunes PC; Yoriyaz H
Med Phys; 2013 May; 40(5):051717. PubMed ID: 23635265
[TBL] [Abstract][Full Text] [Related]
33. A method for verification of treatment delivery in HDR prostate brachytherapy using a flat panel detector for both imaging and source tracking.
Smith RL; Haworth A; Panettieri V; Millar JL; Franich RD
Med Phys; 2016 May; 43(5):2435. PubMed ID: 27147354
[TBL] [Abstract][Full Text] [Related]
34. Validation of MRI to TRUS registration for high-dose-rate prostate brachytherapy.
Poulin E; Boudam K; Pinter C; Kadoury S; Lasso A; Fichtinger G; Ménard C
Brachytherapy; 2018; 17(2):283-290. PubMed ID: 29331575
[TBL] [Abstract][Full Text] [Related]
35. A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapy.
Strom TJ; Wilder RB; Fernandez DC; Mellon EA; Saini AS; Hunt DC; Pow-Sang JM; Spiess PE; Sexton WJ; Poch MA; Biagioli MC
Radiother Oncol; 2014 Apr; 111(1):126-31. PubMed ID: 24746567
[TBL] [Abstract][Full Text] [Related]
36. BrachyView: Reconstruction of seed positions and volume of an LDR prostate brachytherapy patient plan using a baseline subtraction algorithm.
Brennen T; Cutajar DL; Alnaghy S; Bucci J; Bece A; Enari K; Favoino M; Carriero F; Tartaglia M; Galli L; Lerch M; Rosenfeld AB; Petasecca M
Phys Med; 2019 Oct; 66():66-76. PubMed ID: 31563727
[TBL] [Abstract][Full Text] [Related]
37. Monte Carlo study of the impact of a magnetic field on the dose distribution in MRI-guided HDR brachytherapy using Ir-192.
Beld E; Seevinck PR; Lagendijk JJ; Viergever MA; Moerland MA
Phys Med Biol; 2016 Sep; 61(18):6791-6807. PubMed ID: 27580406
[TBL] [Abstract][Full Text] [Related]
38. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
[TBL] [Abstract][Full Text] [Related]
39. Six-probe scintillator dosimeter for treatment verification in HDR-brachytherapy.
Gonod M; Suarez MA; Avila CC; Karakhanyan V; Eustache C; Laskri S; Crouzilles J; Vinchant JF; Aubignac L; Grosjean T
Med Phys; 2023 Nov; 50(11):7192-7202. PubMed ID: 37738612
[TBL] [Abstract][Full Text] [Related]
40. Feasibility of online adaptive HDR prostate brachytherapy: A novel treatment concept.
Koprivec D; Rosenfeld A; Cutajar D; Petasecca M; Howie A; Bucci J; Poder J
Brachytherapy; 2022; 21(6):943-955. PubMed ID: 36068155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
